loading
전일 마감가:
$56.50
열려 있는:
$56.33
하루 거래량:
463.25K
Relative Volume:
0.56
시가총액:
$3.05B
수익:
$665.13M
순이익/손실:
$64.50M
주가수익비율:
47.54
EPS:
1.1442
순현금흐름:
$185.87M
1주 성능:
+3.33%
1개월 성능:
+14.22%
6개월 성능:
+68.06%
1년 성능:
+60.22%
1일 변동 폭
Value
$54.21
$57.33
1주일 범위
Value
$51.84
$57.65
52주 변동 폭
Value
$29.16
$57.65

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name
명칭
Supernus Pharmaceuticals Inc
Name
전화
301-838-2500
Name
주소
9715 KEY WEST AVENUE, ROCKVILLE, MD
Name
직원
674
Name
트위터
@Supernus_Pharma
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
SUPN's Discussions on Twitter

SUPN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
SUPN
Supernus Pharmaceuticals Inc
54.44 3.17B 665.13M 64.50M 185.87M 1.1442
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.81 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.36 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.245 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.15 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
443.71 19.53B 3.08B 1.24B 1.07B 25.61

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-09 업그레이드 Piper Sandler Neutral → Overweight
2025-07-30 업그레이드 Cantor Fitzgerald Neutral → Overweight
2025-02-19 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2025-01-06 개시 Cantor Fitzgerald Overweight
2024-09-11 다운그레이드 Piper Sandler Overweight → Neutral
2023-01-03 재개 Jefferies Buy
2021-12-01 재개 Jefferies Buy
2021-04-13 업그레이드 Jefferies Hold → Buy
2020-06-16 업그레이드 Piper Sandler Neutral → Overweight
2020-06-15 재개 Jefferies Hold
2019-11-08 다운그레이드 Berenberg Buy → Hold
2019-11-07 다운그레이드 Stifel Buy → Hold
2019-11-06 다운그레이드 Jefferies Buy → Hold
2018-11-12 재확인 B. Riley FBR Buy
2018-01-18 재확인 B. Riley FBR, Inc. Buy
2017-12-28 재확인 B. Riley FBR, Inc. Buy
2017-12-04 업그레이드 Janney Neutral → Buy
2017-11-08 업그레이드 Stifel Hold → Buy
2017-10-19 개시 FBR & Co. Buy
2017-09-19 다운그레이드 Stifel Buy → Hold
2017-07-17 다운그레이드 Piper Jaffray Overweight → Neutral
2017-07-14 개시 Janney Neutral
2017-06-01 업그레이드 Piper Jaffray Neutral → Overweight
2016-07-18 다운그레이드 Northland Capital Outperform → Market Perform
2016-07-18 다운그레이드 Piper Jaffray Overweight → Neutral
2016-02-08 업그레이드 Jefferies Hold → Buy
2015-11-05 재확인 Northland Capital Outperform
2015-10-28 개시 Northland Capital Outperform
모두보기

Supernus Pharmaceuticals Inc 주식(SUPN)의 최신 뉴스

pulisher
07:44 AM

Supernus a new buy at BofA on 'underappreciated' CNS assets - MSN

07:44 AM
pulisher
12:20 PM

Can Supernus Pharmaceuticals Inc. stock continue upward trendPortfolio Performance Report & Long Hold Capital Preservation Plans - newser.com

12:20 PM
pulisher
12:16 PM

Why Supernus Pharmaceuticals Inc. stock remains undervaluedBond Market & AI Forecasted Entry and Exit Points - newser.com

12:16 PM
pulisher
Oct 30, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $55.95 - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Supernus Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Update & Consistent Profit Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsJuly 2025 Price Swings & High Conviction Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Long term hold vs stop loss in Supernus Pharmaceuticals Inc.IPO Watch & Risk Controlled Swing Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Top chart patterns to watch in Supernus Pharmaceuticals Inc.Watch List & Verified Short-Term Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What institutional flow reveals about Supernus Pharmaceuticals Inc.Treasury Yields & Community Verified Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals Inc Stock Analysis and ForecastQuarterly Earnings Review & Rapid Portfolio Appreciation - earlytimes.in

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Gains Market Attention with Key CNS Drugs - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

Can Supernus Pharmaceuticals Sustain Momentum After 13% Jump on Neuroscience Pipeline News? - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $53.28 - Markets Mojo

Oct 29, 2025
pulisher
Oct 29, 2025

BofA Securities Initiates Supernus Pharmaceuticals at Buy With $65 Price Target - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

B of A Securities Initiates Coverage on SUPN with a Buy Rating | - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Price Target Increased by 32.88% to 59.36 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

B of A Securities Initiates Coverage of Supernus Pharmaceuticals (SUPN) with Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Supernus Pharmaceuticals Inc. stock near bottom after decline2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Using data models to predict Supernus Pharmaceuticals Inc. stock movementTrade Analysis Summary & Safe Entry Trade Reports - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

It’s Clear How Big Money Flows Lift Supernus - Yahoo Finance

Oct 29, 2025
pulisher
Oct 28, 2025

Will Supernus Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Selloffs & Safe Entry Point Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline - sharewise.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Supernus Pharmaceuticals Inc. stock supported by strong fundamentalsWeekly Investment Summary & Smart Swing Trading Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Is Supernus Pharmaceuticals Inc. stock attractive after correctionEntry Point & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.2025 Year in Review & Daily Profit Maximizing Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

Sentiment analysis tools applied to Supernus Pharmaceuticals Inc.2025 Investor Takeaways & Risk Managed Trade Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How Supernus Pharmaceuticals Inc. stock reacts to Fed rate cutsTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com

Oct 27, 2025

Supernus Pharmaceuticals Inc (SUPN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Supernus Pharmaceuticals Inc 주식 (SUPN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Khattar Jack A.
President, CEO
Oct 09 '25
Sale
50.57
59,900
3,029,336
1,206,578
NEWHALL CHARLES W III
Director
Oct 09 '25
Sale
50.77
25,000
1,269,234
104,644
$45.58
price up icon 3.74%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.14%
$22.45
price down icon 0.51%
$10.35
price down icon 0.19%
$141.84
price up icon 2.67%
$444.10
price down icon 2.19%
자본화:     |  볼륨(24시간):